David H Miller

发表

High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.

David H. Miller, Roger J Ordidge, Sebastian Brandner, 2010, Brain : a journal of neurology.

Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: A voxel-based analysis study

David H. Miller, Varun Sethi, Nils Muhlert, 2015, Multiple sclerosis.

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.

Anthony O'Hagan, Nicola J Cooper, David H. Miller, 2003, BMJ : British Medical Journal.

Diffusion tensor imaging in early relapsing-remitting multiple sclerosis

Olga Ciccarelli, Alan J Thompson, Gareth J Barker, 2001, Multiple sclerosis.

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

Alan J Thompson, Charles Crawley, Madhan Kolappan, 2012, The Lancet Neurology.

TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis

Alan J Thompson, Waqar Rashid, A. Thompson, 2010, Multiple sclerosis.

The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases

David H. Miller, Jeremy Chataway, Michael H Barnett, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis

Stephen J. Jones, Patricio G Schlottmann, David H. Miller, 2005, Annals of neurology.

Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study.

Ludwig Kappos, Xavier Montalban, Frederik Barkhof, 2009, Archives of neurology.

Visual recovery following acute optic neuritis--a clinical, electrophysiological and magnetic resonance imaging study.

Stephen J. Jones, Alan J Thompson, Gordon T Plant, 2004, Journal of neurology.

Adaptive cortical plasticity in higher visual areas after acute optic neuritis

Stephen J. Jones, David H. Miller, Alan J Thompson, 2005, Annals of neurology.

Vitamin D as an early predictor of multiple sclerosis activity and progression.

Ludwig Kappos, Frederik Barkhof, Gilles Edan, 2014, JAMA neurology.

Association between pathological and MRI findings in multiple sclerosis

Massimo Filippi, Frederik Barkhof, Bradley J Erickson, 2012, The Lancet Neurology.

Primary-progressive multiple sclerosis

David H. Miller, S. Leary, David H Miller, 2007, The Lancet Neurology.

Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis

David H. Miller, Alan J Thompson, Gordon T Plant, 2002, Annals of neurology.

Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study

Christian M Kerskens, Frauke Zipp, Arno Villringer, 2004, Multiple sclerosis.

Imaging outcomes for trials of remyelination in multiple sclerosis

David H. Miller, Claudia A M Wheeler-Kingshott, C. Wheeler-Kingshott, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Ludwig Kappos, Ivan Rektor, David H. Miller, 2008, The Lancet.

Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study.

Mara Cercignani, Jorge Sepulcre, David H. Miller, 2006, Archives of neurology.

Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis.

Mara Cercignani, Olga Ciccarelli, Alan J Thompson, 2008, Archives of neurology.

Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis.

Stephen J. Jones, David H. Miller, Gordon T Plant, 2004, AJNR. American journal of neuroradiology.

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

Ludwig Kappos, Xavier Montalban, David H. Miller, 2016, The Lancet.

A serial MRI study following optic nerve mean area in acute optic neuritis.

Stephen J. Jones, David H. Miller, Alan J Thompson, 2004, Brain : a journal of neurology.

Magnetic resonance imaging measures of brain atrophy in multiple sclerosis

Nick C Fox, David H. Miller, V. Anderson, 2006, Journal of magnetic resonance imaging : JMRI.

Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis

Charlotte Graham, John C Dalrymple-Alford, Tracy R Melzer, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

A magnetization transfer analysis of the thalamus in schizophrenia.

Gareth J Barker, J. Foong, G. Barker, 2002, The Journal of neuropsychiatry and clinical neurosciences.

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis

Marco Rovaris, Massimo Filippi, Xavier Montalban, 2008, Multiple sclerosis.

MRI acquisition and analysis protocol for in vivo intraorbital optic nerve segmentation at 3T.

David H. Miller, Claudia A M Wheeler-Kingshott, C. Wheeler-Kingshott, 2013, Investigative ophthalmology & visual science.

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

Marco Rovaris, Massimo Filippi, Xavier Montalban, 2007, The Lancet Neurology.

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes.

David H. Miller, Alan J Thompson, Gordon T Plant, 2004, Brain : a journal of neurology.

The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM‐based segmentation methodology

Alan J Thompson, Geoffrey J M Parker, A. Thompson, 2002, Journal of magnetic resonance imaging : JMRI.

Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis

Olga Ciccarelli, Alan J Thompson, Nikos Gorgoraptis, 2010, Multiple sclerosis.

Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually‐edited SIENA and SIENAX

Marco Rovaris, Massimo Filippi, Christian Enzinger, 2007, Journal of magnetic resonance imaging : JMRI.

Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.

Ludwig Kappos, Frederik Barkhof, Gilles Edan, 2007, Archives of neurology.

Assessment and correction of B1‐induced errors in magnetization transfer ratio measurements

Massimo Filippi, Frederik Barkhof, Stefan Ropele, 2005, Magnetic resonance in medicine.

Brain atrophy, interferon beta, and treatment trials in multiple sclerosis

David H. Miller, David H Miller, David H. Miller, 2004, The Lancet.

Corpus callosum damage predicts disability progression and cognitive dysfunction in primary‐progressive MS after five years

Mara Cercignani, David H. Miller, Olga Ciccarelli, 2013, Human brain mapping.

Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI

Xavier Golay, David H. Miller, Varun Sethi, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study

Marco Rovaris, Massimo Filippi, Massimiliano Calabrese, 2011, Multiple sclerosis.

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Ludwig Kappos, Gavin Giovannoni, Frances Lynn, 2006, The New England journal of medicine.

Application of a B‐spline active surface technique to the measurement of cervical cord volume in multiple sclerosis from three‐dimensional MR images

Olivier Coulon, Alan J Thompson, Simon R Arridge, 2003, Journal of magnetic resonance imaging : JMRI.

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

Mara Cercignani, Lluís Ramió-Torrentà, David H. Miller, 2005, Brain : a journal of neurology.

Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups

Varun Sethi, Nils Muhlert, M. Ron, 2014, Multiple sclerosis.

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Ludwig Kappos, Frederik Barkhof, Gilles Edan, 2007, The Lancet.

Reduced R2′ in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content

Xavier Golay, David Paling, X. Golay, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Diagnosis of multiple sclerosis: progress and challenges

David H. Miller, Franz Fazekas, F. Fazekas, 2017, The Lancet.

Clinically isolated syndromes

David H. Miller, Olga Ciccarelli, O. Ciccarelli, 2012, The Lancet Neurology.

Cerebral Atrophy Measurement in Clinically Isolated Syndromes and Relapsing Remitting Multiple Sclerosis: A Comparison of Registration‐Based Methods

Chris Frost, Nick C Fox, Waqar Rashid, 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.

Xavier Golay, David H. Miller, Frank Riemer, 2013, Brain : a journal of neurology.

Optic radiation changes after optic neuritis detected by tractography‐based group mapping

Geoff J M Parker, David H. Miller, Olga Ciccarelli, 2005, Human brain mapping.

Effects of formalin fixation on magnetic resonance indices in multiple sclerosis cortical gray matter

David H. Miller, Sebastian Brandner, Klaus Schmierer, 2010, Journal of magnetic resonance imaging : JMRI.

Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis

Massimo Filippi, Frederik Barkhof, David H. Miller, 2003, Journal of magnetic resonance imaging : JMRI.